Pfizer Ltd. - Research Center
500680 PFIZER Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 3,161.55 | 2,818.66 | 2,347.29 | 3,349.74 | 2,965.59 |
| Loan funds | |||||
| Secured loans | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
| Unsecured loans | - | - | - | - | - |
| Total | 3,209.80 | 2,866.91 | 2,395.54 | 3,397.99 | 3,013.84 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 978.90 | 1,050.27 | 1,035.22 | 1,074.42 | 946.23 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 229.65 | 181.14 | 140.92 | 101.56 | 60.04 |
| Net block | 749.25 | 869.13 | 894.30 | 972.86 | 886.19 |
| Capital work-in-progress | 7.93 | 1.15 | 2.76 | 0.76 | - |
| Investments | - | - | - | - | - |
| Net current assets | |||||
| Current assets, loans & advances | 3,243.55 | 3,030.23 | 2,368.84 | 3,431.78 | 3,053.80 |
| Less : current liabilities & provisions | 790.93 | 1,033.60 | 870.36 | 1,007.41 | 926.15 |
| Total net current assets | 2,452.62 | 1,996.63 | 1,498.48 | 2,424.37 | 2,127.65 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 3,209.80 | 2,866.91 | 2,395.54 | 3,397.99 | 3,013.84 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 437.83 | 338.14 | 254.98 | 254.60 | 219.12 |
| Number of equity sharesoutstanding (Lacs) | 457.48 | 457.48 | 457.48 | 457.48 | 457.48 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis